129100-11-4 Usage
Molecular weight
142.2 g/mol
The relative molecular mass of the compound is 142.2 grams per mole.
Spiro-cyclic structure
A six-membered ring fused to a five-membered ring with an oxygen atom.
Stereochemistry
(2S)prefix indicates a stereocenter with an S configuration.
The presence of a chiral center at the second carbon atom, with the S configuration, gives the compound its specific three-dimensional arrangement.
Building block in organic synthesis
Can be used for constructing complex molecular structures.
Due to its unique structure, the compound can serve as a starting material or intermediate in the synthesis of more complex organic molecules.
Potential applications in medicinal chemistry and pharmaceutical research
Unique structural features and possible biological activity.
The compound's distinct structure and properties may make it a valuable candidate for further study in drug development and understanding biological processes.
Diverse potential uses
Chemical and biological research.
The compound's intriguing properties make it a promising subject for investigation in both chemical and biological fields.
Check Digit Verification of cas no
The CAS Registry Mumber 129100-11-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,9,1,0 and 0 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 129100-11:
(8*1)+(7*2)+(6*9)+(5*1)+(4*0)+(3*0)+(2*1)+(1*1)=84
84 % 10 = 4
So 129100-11-4 is a valid CAS Registry Number.
129100-11-4Relevant articles and documents
A protecting group free and scalable approach towards total synthesis of (-)-venlafaxine
Chavan, Subhash P.,Pawar, Kailash P.,Garai, Sumanta
, p. 14468 - 14470 (2014)
A protecting group free asymmetric total synthesis of (-)-venlafaxine is reported. The strategy employs Sharpless epoxidation and regio-selective epoxide ring opening by an in situ generated Gilman reagent as key steps. This paper reports a 53% overall yield in 6 steps for total synthesis of (-)-venlafaxine. This journal is the Partner Organisations 2014.
Conformationally restricted leukotriene antagonists. Asymmetric synthesis of a nor-leukotriene D4 analog. II1
Sabol,Cregge
, p. 27 - 30 (2007/10/02)
Chiral diol 5 is prepared from cyclohexanone and used in the asymmetric synthesis of nor-leukotriene D4 analog 1.
